• OPEN AN ACCOUNT
Indian Indices
Sensex
82,532.19 427.40
( 0.52%)
Global Indices
Nasdaq
51,667.44 -701.11
(-1.34%)
Dow Jones
7,446.91 -135.76
(-1.79%)
Hang Seng
58,984.34 -677.68
(-1.14%)
Nikkei 225
10,703.23 -178.32
(-1.64%)
Forex
USD-INR
94.26 0.34
(0.36%)
EUR-INR
103.88 -0.12
(-0.12%)
GBP-INR
124.50 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.38%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
686.0527542
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
36.31
55758.82
EPS(TTM)
Face Value()
Div & Yield %
93.05
1
0.59
 

Mahindra & Mahindra October sales increase 9% to 1.31 lakh units
Nov 02,2026

Mahindra & Mahindra has sold 1,31,109 units in month of October 2026 compared to 1,20,142 units in October 2025, recording a growth of 9%.

Total sales include domestic sales of 1,24,007 units (up 7% YoY) and exports of 7,102 units (up 77% YoY).

The company sold 73,338 passenger vehicle units (up 2% YoY) and 50,669 commercial vehicle and three-wheeler units (up 14% YoY) during the month.

 According to Dr. Velusamy R, President, Automotive Business, Mahindra & Mahindra, “October was a landmark month for us, with SUV sales topping at 73338 units and total vehicle sales of 131109, both the highest we have ever clocked in a month. The festive season, together with a refreshed portfolio, kept demand strong across SUVs, pick-ups and three-wheelers. Our first CNG vehicle, the XUV 3XO ZNG has also seen strong traction with customers.”